Ebola Bundibugyo Outbreak in DRC and Uganda: Journal Article Summary and FDA-Approved Therapies Overview (guidelinecentral.com)

• Bundibugyo ebolavirus outbreak in DRC and Uganda: >300 suspected cases, 100 deaths, PHEIC declared May 17, 2026.
• No approved vaccines or treatments for Bundibugyo; FDA-approved therapies only for Zaire ebolavirus.
• Overview of four recent journal articles covering epidemiology, modeling, gene expression, and drug discovery.

"A summary of recent medical journal articles on the Ebola outbreak caused by the rare Bundibugyo virus in the Democratic Republic of the Congo and Uganda, with over 300 suspected cases and 100 deaths reported. WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC) on May 17, 2026. CDC implemented enhanced travel screening. No approved vaccines or treatments exist for Bundibugyo virus. The article also lists FDA-approved therapies Inmazeb and Ebanga and vaccine Ervebo for Zaire ebolavirus."